Taysha’s Gene Therapy Manufacturing Facility, Durham, North Carolina

SourcePharmaceutical Technology
Date Published01/27/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Taysha Gene Therapies
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):200
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2023
Capital investment ($):75
City reshored to:Durham
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredgene therapy, adeno-associated virus serotype 9
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Lead time/Time to market, Lean/other business process improvement techniques, Skilled workforce availability/training
Find Reshoring Articles